Who Owns ARKG
Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in ARKG.
Who crossed 5% of ARKG →Positions as of 2026-09-30
Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.
| Manager | Value |
|---|---|
| Midwest Financial Partners Investments, Inc.GENOMIC REV ETF205.2K shtrimmed | $11.1M |
| Client First Investment Management LLCGENOMIC REV ETF22K shtrimmed | $1.2M |
| Post Resch Tallon Group Inc.GENOMIC REV ETF21K shtrimmed | $1.1M |
| TITLEIST ASSET MANAGEMENT, LLCGENOMIC REV ETF7.1K shtrimmed | $385K |
| Farther Finance Advisors, LLCETF1.9K shadded | $103.8K |
| GK Wealth Management LLCGENOMIC REV ETF490 sh— | $26.6K |
| Rosenberg Matthew HamiltonETF201 sh— | $10.9K |
| ARMSTRONG ADVISORY GROUP, INCGENOMIC REV ETF70 shheld | $3.8K |
Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.
More on ARKG
Follow ARKG by email
New trades in ARKG by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.